{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:47:20Z","timestamp":1790930840784,"version":"4.1.0"},"reference-count":225,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,5,13]],"date-time":"2010-05-13T00:00:00Z","timestamp":1273708800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s10620-010-1268-4","type":"journal-article","created":{"date-parts":[[2010,5,12]],"date-time":"2010-05-12T19:00:56Z","timestamp":1273690856000},"page":"2144-2161","source":"Crossref","is-referenced-by-count":65,"title":["Autoantibodies as Prognostic Markers in Autoimmune Liver Disease"],"prefix":"10.1007","volume":"55","author":[{"given":"Albert J.","family":"Czaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,13]]},"reference":[{"key":"1268_CR1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1233533","volume":"29","author":"DP Bogdanos","year":"2009","unstructured":"Bogdanos DP, Mieli-Vergani G, Vergani D. Autoantibodies and their antigens in autoimmune hepatitis. Semin Liver Dis. 2009;29:241\u2013253.","journal-title":"Semin Liver Dis"},{"key":"1268_CR2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(94)90078-7","volume":"107","author":"AJ Czaja","year":"1994","unstructured":"Czaja AJ, Nishioka M, Morshed SA, Hachiya T. Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology. 1994;107:200\u2013207.","journal-title":"Gastroenterology"},{"key":"1268_CR3","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1023\/A:1018809431189","volume":"42","author":"AJ Czaja","year":"1997","unstructured":"Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis. Dig Dis Sci. 1997;42:1688\u20131696.","journal-title":"Dig Dis Sci"},{"key":"1268_CR4","first-page":"621","volume":"38","author":"BH Toh","year":"1979","unstructured":"Toh BH. Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol. 1979;38:621\u2013628.","journal-title":"Clin Exp Immunol"},{"key":"1268_CR5","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI115443","volume":"88","author":"MP Manns","year":"1991","unstructured":"Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest. 1991;88:1370\u20131378.","journal-title":"J Clin Invest"},{"key":"1268_CR6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/jlts.2002.33485","volume":"8","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ. Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance. Liver Transpl. 2002;8:505\u2013513.","journal-title":"Liver Transpl"},{"key":"1268_CR7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0065-2423(05)40004-9","volume":"40","author":"AJ Czaja","year":"2005","unstructured":"Czaja AJ. Autoantibodies in autoimmune liver disease. Adv Clin Chem. 2005;40:127\u2013164.","journal-title":"Adv Clin Chem"},{"key":"1268_CR8","unstructured":"Manns MP, Czaja AJ, Gorham JD, et al. Practice Guidelines of the American Association for the Study of Liver Diseases. Diagnosis and management of autoimmune hepatitis. Hepatology. (in press)."},{"key":"1268_CR9","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJM198905253202104","volume":"320","author":"J Water Van de","year":"1989","unstructured":"Van de Water J, Cooper A, Surh CD, et al. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. N Engl J Med. 1989;320:1377\u20131380.","journal-title":"N Engl J Med"},{"key":"1268_CR10","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.142.11.3815","volume":"142","author":"DR Fregeau","year":"1989","unstructured":"Fregeau DR, Davis PA, Danner DJ, et al. Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha-ketoacid dehydrogenase complex. J Immunol. 1989;142:3815\u20133820.","journal-title":"J Immunol"},{"key":"1268_CR11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Gershwin ME, Poupon R, et al. AASLD practice guidelines. Primary biliary cirrhosis. Hepatology. 2009;50:291\u2013308.","journal-title":"Hepatology"},{"key":"1268_CR12","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.1840070626","volume":"7","author":"JC Homberg","year":"1987","unstructured":"Homberg JC, Abuaf N, Bernard O, et al. Chronic active hepatitis associated with antiliver\/kidney microsome antibody type 1: a second type of \u201cautoimmune\u201d hepatitis. Hepatology. 1987;7:1333\u20131339.","journal-title":"Hepatology"},{"key":"1268_CR13","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/0016-5085(92)91518-9","volume":"103","author":"AJ Czaja","year":"1992","unstructured":"Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver\/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology. 1992;103:1290\u20131295.","journal-title":"Gastroenterology"},{"key":"1268_CR14","first-page":"1206","volume":"90","author":"AJ Czaja","year":"1995","unstructured":"Czaja AJ, Manns MP. The validity and importance of subtypes in autoimmune hepatitis: a point of view. Am J Gastroenterol. 1995;90:1206\u20131211.","journal-title":"Am J Gastroenterol"},{"key":"1268_CR15","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1572-0241.1999.01229.x","volume":"94","author":"PL Bittencourt","year":"1999","unstructured":"Bittencourt PL, Goldberg AC, Cancado EL, et al. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Am J Gastroenterol. 1999;94:1906\u20131913.","journal-title":"Am J Gastroenterol"},{"key":"1268_CR16","first-page":"2197","volume":"92","author":"AJ Czaja","year":"1997","unstructured":"Czaja AJ, Kruger M, Santrach PJ, Moore SB, Manns MP. Genetic distinctions between types 1 and 2 autoimmune hepatitis. Am J Gastroenterol. 1997;92:2197\u20132200.","journal-title":"Am J Gastroenterol"},{"key":"1268_CR17","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.3748\/wjg.v11.i12.1862","volume":"11","author":"P Muratori","year":"2005","unstructured":"Muratori P, Czaja AJ, Muratori L, et al. Genetic distinctions between autoimmune hepatitis in Italy and North America. World J Gastroenterol. 2005;11:1862\u20131866.","journal-title":"World J Gastroenterol"},{"key":"1268_CR18","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1053\/gast.1997.v112.pm9178696","volume":"112","author":"MD Strettell","year":"1997","unstructured":"Strettell MD, Donaldson PT, Thomson LJ, et al. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology. 1997;112:2028\u20132035.","journal-title":"Gastroenterology"},{"key":"1268_CR19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.510250211","volume":"25","author":"AJ Czaja","year":"1997","unstructured":"Czaja AJ, Strettell MD, Thomson LJ, et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology. 1997;25:317\u2013323.","journal-title":"Hepatology"},{"key":"1268_CR20","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jhep.2004.02.023","volume":"40","author":"I Djilali-Saiah","year":"2004","unstructured":"Djilali-Saiah I, Renous R, Caillat-Zucman S, Debray D, Alvarez F. Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients. J Hepatol. 2004;40:904\u2013909.","journal-title":"J Hepatol"},{"key":"1268_CR21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","volume":"25","author":"GV Gregorio","year":"1997","unstructured":"Gregorio GV, Portmann B, Reid F, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology. 1997;25:541\u2013547.","journal-title":"Hepatology"},{"key":"1268_CR22","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0168-8278(99)80096-8","volume":"30","author":"AJ Czaja","year":"1999","unstructured":"Czaja AJ. Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol. 1999;30:394\u2013401.","journal-title":"J Hepatol"},{"key":"1268_CR23","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/MCG.0b013e318154af74","volume":"42","author":"S Luth","year":"2008","unstructured":"Luth S, Herkel J, Kanzler S, et al. Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis. J Clin Gastroenterol. 2008;42:926\u2013930.","journal-title":"J Clin Gastroenterol"},{"key":"1268_CR24","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/0016-5085(90)90488-M","volume":"99","author":"L Heseltine","year":"1990","unstructured":"Heseltine L, Turner IB, Fussey SP, et al. Primary biliary cirrhosis. Quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression. Gastroenterology. 1990;99:1786\u20131792.","journal-title":"Gastroenterology"},{"key":"1268_CR25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.510250103","volume":"25","author":"MD Norstrand Van","year":"1997","unstructured":"Van Norstrand MD, Malinchoc M, Lindor KD, et al. Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression. Hepatology. 1997;25:6\u201311.","journal-title":"Hepatology"},{"key":"1268_CR26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.21749","volume":"46","author":"KN Lazaridis","year":"2007","unstructured":"Lazaridis KN, Juran BD, Boe GM, et al. Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis. Hepatology. 2007;46:785\u2013792.","journal-title":"Hepatology"},{"key":"1268_CR27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1034\/j.1600-0528.2002.017402.x","volume":"174","author":"ME Gershwin","year":"2000","unstructured":"Gershwin ME, Ansari AA, Mackay IR, et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev. 2000;174:210\u2013225.","journal-title":"Immunol Rev"},{"key":"1268_CR28","first-page":"211","volume":"20","author":"JL Senecal","year":"1993","unstructured":"Senecal JL, Ichiki S, Girard D, Raymond Y. Autoantibodies to nuclear lamins and to intermediate filament proteins: natural, pathologic or pathogenic? J Rheumatol. 1993;20:211\u2013219.","journal-title":"J Rheumatol"},{"key":"1268_CR29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0950-3528(95)90058-6","volume":"9","author":"AJ Czaja","year":"1995","unstructured":"Czaja AJ. Autoantibodies. Baillieres Clin Gastroenterol. 1995;9:723\u2013744.","journal-title":"Baillieres Clin Gastroenterol"},{"key":"1268_CR30","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1159\/000242476","volume":"30","author":"KE Meyers","year":"2009","unstructured":"Meyers KE, Christensen M, Madaio MP. Modeling of human anti-GBM antibody-alpha3(IV)NC1 interactions predicts antigenic cross-linking through contact of both heavy chains with repeating epitopes on alpha3(IV)NC1. Am J Nephrol. 2009;30:474\u2013480.","journal-title":"Am J Nephrol"},{"key":"1268_CR31","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/ki.2009.348","volume":"76","author":"J Zhao","year":"2009","unstructured":"Zhao J, Cui Z, Yang R, et al. Anti-glomerular basement membrane autoantibodies against different target antigens are associated with disease severity. Kidney Int. 2009;76:1108\u20131115.","journal-title":"Kidney Int"},{"key":"1268_CR32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hep.1840120120","volume":"12","author":"M Manns","year":"1990","unstructured":"Manns M, Zanger U, Gerken G, et al. Patients with type II autoimmune hepatitis express functionally intact cytochrome P-450 db1 that is inhibited by LKM-1 autoantibodies in vitro but not in vivo. Hepatology. 1990;12:127\u2013132.","journal-title":"Hepatology"},{"key":"1268_CR33","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/0016-5085(93)90656-W","volume":"104","author":"AJ Czaja","year":"1993","unstructured":"Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Homburger HA. The nature and prognosis of severe cryptogenic chronic active hepatitis. Gastroenterology. 1993;104:1755\u20131761.","journal-title":"Gastroenterology"},{"key":"1268_CR34","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s10620-006-9665-4","volume":"52","author":"DJ Gassert","year":"2007","unstructured":"Gassert DJ, Garcia H, Tanaka K, Reinus JF. Corticosteroid-responsive cryptogenic chronic hepatitis: evidence for seronegative autoimmune hepatitis. Dig Dis Sci. 2007;52:2433\u20132437.","journal-title":"Dig Dis Sci"},{"key":"1268_CR35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-0028-1109146","volume":"47","author":"S Heringlake","year":"2009","unstructured":"Heringlake S, Schutte A, Flemming P, et al. Presumed cryptogenic liver disease in Germany: high prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology. Z Gastroenterol. 2009;47:417\u2013423.","journal-title":"Z Gastroenterol"},{"key":"1268_CR36","first-page":"247","volume":"90","author":"MA Lacerda","year":"1995","unstructured":"Lacerda MA, Ludwig J, Dickson ER, Jorgensen RA, Lindor KD. Antimitochondrial antibody-negative primary biliary cirrhosis. Am J Gastroenterol. 1995;90:247\u2013249.","journal-title":"Am J Gastroenterol"},{"key":"1268_CR37","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.510250507","volume":"25","author":"P Invernizzi","year":"1997","unstructured":"Invernizzi P, Crosignani A, Battezzati PM, et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology. 1997;25:1090\u20131095.","journal-title":"Hepatology"},{"key":"1268_CR38","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","volume":"1","author":"M Manns","year":"1987","unstructured":"Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Buschenfelde KH. Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet. 1987;1:292\u2013294.","journal-title":"Lancet"},{"key":"1268_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840180102","volume":"18","author":"E Stechemesser","year":"1993","unstructured":"Stechemesser E, Klein R, Berg PA. Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis. Hepatology. 1993;18:1\u20139.","journal-title":"Hepatology"},{"key":"1268_CR40","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.89.20.9739","volume":"89","author":"C Gelpi","year":"1992","unstructured":"Gelpi C, Sontheimer EJ, Rodriguez-Sanchez JL. Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion. Proc Natl Acad Sci USA. 1992;89:9739\u20139743.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1268_CR41","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0168-8278(00)80361-X","volume":"33","author":"E Ballot","year":"2000","unstructured":"Ballot E, Homberg JC, Johanet C. Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis. J Hepatol. 2000;33:208\u2013215.","journal-title":"J Hepatol"},{"key":"1268_CR42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.51.2.259","volume":"51","author":"M Baeres","year":"2002","unstructured":"Baeres M, Herkel J, Czaja AJ, et al. Establishment of standardised SLA\/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Gut. 2002;51:259\u2013264.","journal-title":"Gut"},{"key":"1268_CR43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/0891693021000054101","volume":"35","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Shums Z, Norman GL. Frequency and significance of antibodies to soluble liver antigen\/liver pancreas in variant autoimmune hepatitis. Autoimmunity. 2002;35:475\u2013483.","journal-title":"Autoimmunity"},{"key":"1268_CR44","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1478-3231.2009.01986.x","volume":"29","author":"V Eyraud","year":"2009","unstructured":"Eyraud V, Chazouilleres O, Ballot E, et al. Significance of antibodies to soluble liver antigen\/liver pancreas: a large French study. Liver Int. 2009;29:857\u2013864.","journal-title":"Liver Int"},{"key":"1268_CR45","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/0016-5085(93)90160-E","volume":"105","author":"AJ Czaja","year":"1993","unstructured":"Czaja AJ, Carpenter HA, Manns MP. Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastroenterology. 1993;105:1522\u20131528.","journal-title":"Gastroenterology"},{"key":"1268_CR46","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0168-8278(99)80342-0","volume":"31","author":"S Kanzler","year":"1999","unstructured":"Kanzler S, Weidemann C, Gerken G, et al. Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis. J Hepatol. 1999;31:635\u2013640.","journal-title":"J Hepatol"},{"key":"1268_CR47","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/0891693021000056712","volume":"35","author":"S Vitozzi","year":"2002","unstructured":"Vitozzi S, Djilali-Saiah I, Lapierre P, Alvarez F. Anti-soluble liver antigen\/liver-pancreas (SLA\/LP) antibodies in pediatric patients with autoimmune hepatitis. Autoimmunity. 2002;35:485\u2013492.","journal-title":"Autoimmunity"},{"key":"1268_CR48","doi-asserted-by":"crossref","unstructured":"Czaja AJ, Manns MP. Advances in the diagnosis, pathogenesis and management of autoimmune hepatitis. Gastroenterology (in press).","DOI":"10.1053\/j.gastro.2010.04.053"},{"key":"1268_CR49","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1478-3231.2005.01079.x","volume":"25","author":"AX Torres-Collado","year":"2005","unstructured":"Torres-Collado AX, Czaja AJ, Gelpi C. Anti-tRNP(ser)sec\/SLA\/LP autoantibodies. Comparative study using in-house ELISA with a recombinant 48.8-kDa protein, immunoblot, and analysis of immunoprecipitated RNAs. Liver Int. 2005;25:410\u2013419.","journal-title":"Liver Int"},{"key":"1268_CR50","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/jhep.2002.32092","volume":"35","author":"Y Ma","year":"2002","unstructured":"Ma Y, Okamoto M, Thomas MG, et al. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology. 2002;35:658\u2013664.","journal-title":"Hepatology"},{"key":"1268_CR51","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1572-0241.2002.05479.x","volume":"97","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Donaldson PT, Lohse AW. Antibodies to soluble liver antigen\/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis. Am J Gastroenterol. 2002;97:413\u2013419.","journal-title":"Am J Gastroenterol"},{"key":"1268_CR52","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0016-5085(92)90041-V","volume":"103","author":"T Seki","year":"1992","unstructured":"Seki T, Ota M, Furuta S, et al. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology. 1992;103:1041\u20131047.","journal-title":"Gastroenterology"},{"key":"1268_CR53","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jhep.2004.12.019","volume":"42","author":"K Yoshizawa","year":"2005","unstructured":"Yoshizawa K, Ota M, Katsuyama Y, et al. Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis. J Hepatol. 2005;42:578\u2013584.","journal-title":"J Hepatol"},{"key":"1268_CR54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0896-8411(03)00084-2","volume":"21","author":"H Miyakawa","year":"2003","unstructured":"Miyakawa H, Kawashima Y, Kitazawa E, et al. Low frequency of anti-SLA\/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay. J Autoimmun. 2003;21:77\u201382.","journal-title":"J Autoimmun"},{"key":"1268_CR55","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08916930410001686260","volume":"37","author":"S Vitozzi","year":"2004","unstructured":"Vitozzi S, Lapierre P, Djilali-Saiah I, et al. Anti-soluble liver antigen (SLA) antibodies in chronic HCV infection. Autoimmunity. 2004;37:217\u2013222.","journal-title":"Autoimmunity"},{"key":"1268_CR56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-4-2","volume":"4","author":"EI Rigopoulou","year":"2007","unstructured":"Rigopoulou EI, Mytilinaiou M, Romanidou O, Liaskos C, Dalekos GN. Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis. J Autoimmune Dis. 2007;4:2.","journal-title":"J Autoimmune Dis"},{"key":"1268_CR57","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","volume":"355","author":"I Wies","year":"2000","unstructured":"Wies I, Brunner S, Henninger J, et al. Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis. Lancet. 2000;355:1510\u20131515.","journal-title":"Lancet"},{"key":"1268_CR58","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/jhep.2001.22218","volume":"33","author":"M Volkmann","year":"2001","unstructured":"Volkmann M, Martin L, Baurle A, et al. Soluble liver antigen: isolation of a 35-kD recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis. Hepatology. 2001;33:591\u2013596.","journal-title":"Hepatology"},{"key":"1268_CR59","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2249.2000.01280.x","volume":"121","author":"M Costa","year":"2000","unstructured":"Costa M, Rodriguez-Sanchez JL, Czaja AJ, Gelpi C. Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis. Clin Exp Immunol. 2000;121:364\u2013374.","journal-title":"Clin Exp Immunol"},{"key":"1268_CR60","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/jhep.2002.30699","volume":"35","author":"J Herkel","year":"2002","unstructured":"Herkel J, Heidrich B, Nieraad N, et al. Fine specificity of autoantibodies to soluble liver antigen and liver\/pancreas. Hepatology. 2002;35:403\u2013408.","journal-title":"Hepatology"},{"key":"1268_CR61","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1053\/j.gastro.2008.07.029","volume":"135","author":"H Mix","year":"2008","unstructured":"Mix H, Weiler-Normann C, Thimme R, et al. Identification of CD4 T-cell epitopes in soluble liver antigen\/liver pancreas autoantigen in autoimmune hepatitis. Gastroenterology. 2008;135:2107\u20132118.","journal-title":"Gastroenterology"},{"key":"1268_CR62","first-page":"266","volume":"24","author":"K Lidman","year":"1976","unstructured":"Lidman K, Biberfeld G, Fagraeus A, et al. Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis. Clin Exp Immunol. 1976;24:266\u2013272.","journal-title":"Clin Exp Immunol"},{"key":"1268_CR63","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/0891693021000054066","volume":"35","author":"P Muratori","year":"2002","unstructured":"Muratori P, Muratori L, Agostinelli D, et al. Smooth muscle antibodies and type 1 autoimmune hepatitis. Autoimmunity. 2002;35:497\u2013500.","journal-title":"Autoimmunity"},{"key":"1268_CR64","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jcp.2005.027367","volume":"59","author":"A Granito","year":"2006","unstructured":"Granito A, Muratori L, Muratori P, et al. Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. J Clin Pathol. 2006;59:280\u2013284.","journal-title":"J Clin Pathol"},{"key":"1268_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(90)90291-3","volume":"130","author":"M Fusconi","year":"1990","unstructured":"Fusconi M, Cassani F, Zauli D, et al. Anti-actin antibodies: a new test for an old problem. J Immunol Methods. 1990;130:1\u20138.","journal-title":"J Immunol Methods"},{"key":"1268_CR66","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1196\/annals.1313.028","volume":"1050","author":"P Chretien-Leprince","year":"2005","unstructured":"Chretien-Leprince P, Ballot E, Andre C, et al. Diagnostic value of anti-F-actin antibodies in a French multicenter study. Ann NY Acad Sci. 2005;1050:266\u2013273.","journal-title":"Ann NY Acad Sci"},{"key":"1268_CR67","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jcp.29.5.403","volume":"29","author":"GF Bottazzo","year":"1976","unstructured":"Bottazzo GF, Florin-Christensen A, Fairfax A, et al. Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol. 1976;29:403\u2013410.","journal-title":"J Clin Pathol"},{"key":"1268_CR68","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.autrev.2009.02.023","volume":"8","author":"A Soares","year":"2009","unstructured":"Soares A, Cunha R, Rodrigues F, Ribeiro H. Smooth muscle autoantibodies with F-actin specificity. Autoimmun Rev. 2009;8:713\u2013716.","journal-title":"Autoimmun Rev"},{"key":"1268_CR69","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/jcla.20274","volume":"22","author":"V Aubert","year":"2008","unstructured":"Aubert V, Pisler IG, Spertini F. Improved diagnoses of autoimmune hepatitis using an anti-actin ELISA. J Clin Lab Anal. 2008;22:340\u2013345.","journal-title":"J Clin Lab Anal"},{"key":"1268_CR70","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1111\/j.1572-0241.2006.00830.x","volume":"101","author":"C Frenzel","year":"2006","unstructured":"Frenzel C, Herkel J, Luth S, et al. Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis. Am J Gastroenterol. 2006;101:2731\u20132736.","journal-title":"Am J Gastroenterol"},{"key":"1268_CR71","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jim.2008.07.011","volume":"338","author":"R Martinez-Neira","year":"2008","unstructured":"Martinez-Neira R, dos Remedios CG, Mackay IR. An actin-myosin functional assay for analysis of smooth muscle (anti-microfilament) autoantibodies in human plasma. J Immunol Methods. 2008;338:63\u201366.","journal-title":"J Immunol Methods"},{"key":"1268_CR72","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/jaut.2001.0540","volume":"17","author":"EL Cancado","year":"2001","unstructured":"Cancado EL, Abrantes-Lemos CP, Vilas-Boas LS, et al. Thermolabile and calcium-dependent serum factor interferes with polymerized actin, and impairs anti-actin antibody detection. J Autoimmun. 2001;17:223\u2013228.","journal-title":"J Autoimmun"},{"key":"1268_CR73","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/08916930701619896","volume":"41","author":"D Villalta","year":"2008","unstructured":"Villalta D, Bizzaro N, Da Re M, et al. Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders. Autoimmunity. 2008;41:105\u2013110.","journal-title":"Autoimmunity"},{"key":"1268_CR74","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/00313020903071413","volume":"41","author":"BH Toh","year":"2009","unstructured":"Toh BH, Taylor R, Pollock W. F-actin reactive smooth muscle antibody in subjects with normal liver function. Pathology. 2009;41:572\u2013575.","journal-title":"Pathology"},{"key":"1268_CR75","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jcla.20167","volume":"21","author":"TD Jaskowski","year":"2007","unstructured":"Jaskowski TD, Konnick EQ, Ashwood ER, Litwin CM, Hill HR. Prevalence of IgG autoantibody against F-actin in patients suspected of having autoimmune or acute viral hepatitis. J Clin Lab Anal. 2007;21:249\u2013253.","journal-title":"J Clin Lab Anal"},{"key":"1268_CR76","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0896-8411(03)00036-2","volume":"20","author":"A Zamanou","year":"2003","unstructured":"Zamanou A, Samiotaki M, Panayotou G, Margaritis L, Lymberi P. Fine specificity and subclasses of IgG anti-actin autoantibodies differ in health and disease. J Autoimmun. 2003;20:333\u2013344.","journal-title":"J Autoimmun"},{"key":"1268_CR77","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00005176-199311000-00007","volume":"17","author":"G Maggiore","year":"1993","unstructured":"Maggiore G, Veber F, Bernard O, et al. Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents. J Pediatr Gastroenterol Nutr. 1993;17:376\u2013381.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1268_CR78","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/hep.510240515","volume":"24","author":"AJ Czaja","year":"1996","unstructured":"Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology. 1996;24:1068\u20131073.","journal-title":"Hepatology"},{"key":"1268_CR79","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10875-006-9045-z","volume":"26","author":"P Gueguen","year":"2006","unstructured":"Gueguen P, Dalekos G, Nousbaum JB, et al. Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1. J Clin Immunol. 2006;26:495\u2013505.","journal-title":"J Clin Immunol"},{"key":"1268_CR80","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12016-007-8050-1","volume":"34","author":"Y Renaudineau","year":"2008","unstructured":"Renaudineau Y, Dalekos GN, Gueguen P, Zachou K, Youinou P. Anti-alpha-actinin antibodies cross-react with anti-ssDNA antibodies in active autoimmune hepatitis. Clin Rev Allergy Immunol. 2008;34:321\u2013325.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1268_CR81","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","volume":"116","author":"P Lapierre","year":"1999","unstructured":"Lapierre P, Hajoui O, Homberg JC, Alvarez F. Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterology. 1999;116:643\u2013649.","journal-title":"Gastroenterology"},{"key":"1268_CR82","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1053\/jhep.2001.27179","volume":"34","author":"L Muratori","year":"2001","unstructured":"Muratori L, Sztul E, Muratori P, et al. Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1. Hepatology. 2001;34:494\u2013501.","journal-title":"Hepatology"},{"key":"1268_CR83","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.yexcr.2003.09.009","volume":"292","author":"R Renous","year":"2004","unstructured":"Renous R, Lapierre P, Djilali-Saiah I, Vitozzi S, Alvarez F. Characterization of the antigenicity of the formiminotransferase-cyclodeaminase in type 2 autoimmune hepatitis. Exp Cell Res. 2004;292:332\u2013341.","journal-title":"Exp Cell Res"},{"key":"1268_CR84","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/eji.200323857","volume":"33","author":"P Lapierre","year":"2003","unstructured":"Lapierre P, Johanet C, Alvarez F. Characterization of the B cell response of patients with anti-liver cytosol autoantibodies in type 2 autoimmune hepatitis. Eur J Immunol. 2003;33:1869\u20131878.","journal-title":"Eur J Immunol"},{"key":"1268_CR85","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.42.5.721","volume":"42","author":"L Muratori","year":"1998","unstructured":"Muratori L, Cataleta M, Muratori P, Lenzi M, Bianchi FB. Liver\/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis. Gut. 1998;42:721\u2013726.","journal-title":"Gut"},{"key":"1268_CR86","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","volume":"8","author":"E Martini","year":"1988","unstructured":"Martini E, Abuaf N, Cavalli F, et al. Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology. 1988;8:1662\u20131666.","journal-title":"Hepatology"},{"key":"1268_CR87","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.1840160407","volume":"16","author":"N Abuaf","year":"1992","unstructured":"Abuaf N, Johanet C, Chretien P, et al. Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis. Hepatology. 1992;16:892\u2013898.","journal-title":"Hepatology"},{"key":"1268_CR88","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0022-1759(95)00192-X","volume":"187","author":"L Muratori","year":"1995","unstructured":"Muratori L, Cataleta M, Muratori P, et al. Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques. J Immunol Methods. 1995;187:259\u2013264.","journal-title":"J Immunol Methods"},{"key":"1268_CR89","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1542-3565(04)00354-4","volume":"2","author":"L Bridoux-Henno","year":"2004","unstructured":"Bridoux-Henno L, Maggiore G, Johanet C, et al. Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody. Clin Gastroenterol Hepatol.. 2004;2:825\u2013830.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"1268_CR90","first-page":"58","volume":"21","author":"S Han","year":"1995","unstructured":"Han S, Tredger M, Gregorio GV, Mieli-Vergani G, Vergani D. Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease. Hepatology. 1995;21:58\u201362.","journal-title":"Hepatology"},{"key":"1268_CR91","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.36.5.749","volume":"36","author":"M Lenzi","year":"1995","unstructured":"Lenzi M, Manotti P, Muratori L, et al. Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection. Gut. 1995;36:749\u2013754.","journal-title":"Gut"},{"key":"1268_CR92","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/clin.1996.0120","volume":"80","author":"E Ballot","year":"1996","unstructured":"Ballot E, Desbos A, Monier JC. Detection on immunoblot of new proteins from the soluble fraction of the cell recognized either by anti-liver-kidney microsome antibodies type 1 or by anti-liver cytosol antibodies type 1\u2013relationship with hepatitis C virus infection. Clin Immunol Immunopathol. 1996;80:245\u2013254.","journal-title":"Clin Immunol Immunopathol"},{"key":"1268_CR93","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaut.2003.11.001","volume":"22","author":"K Beland","year":"2004","unstructured":"Beland K, Lapierre P, Marceau G, Alvarez F. Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection. J Autoimmun. 2004;22:159\u2013166.","journal-title":"J Autoimmun"},{"key":"1268_CR94","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/08916930410001702469","volume":"37","author":"AJ Czaja","year":"2004","unstructured":"Czaja AJ, Shums Z, Norman GL. Nonstandard antibodies as prognostic markers in autoimmune hepatitis. Autoimmunity. 2004;37:195\u2013201.","journal-title":"Autoimmunity"},{"key":"1268_CR95","first-page":"347","volume":"55","author":"IG McFarlane","year":"1984","unstructured":"McFarlane IG, McFarlane BM, Major GN, Tolley P, Williams R. Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP). Clin Exp Immunol. 1984;55:347\u2013354.","journal-title":"Clin Exp Immunol"},{"key":"1268_CR96","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-2008-1040439","volume":"11","author":"T Poralla","year":"1991","unstructured":"Poralla T, Treichel U, Lohr H, Fleischer B. The asialoglycoprotein receptor as target structure in autoimmune liver diseases. Semin Liver Dis. 1991;11:215\u2013222.","journal-title":"Semin Liver Dis"},{"key":"1268_CR97","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/jcp.1041500218","volume":"150","author":"C Enrich","year":"1992","unstructured":"Enrich C, Verges M, Evans WH. Differential expression of asialoglycoprotein receptor subunits in the endocytic compartment during liver regeneration. J Cell Physiol. 1992;150:344\u2013352.","journal-title":"J Cell Physiol"},{"key":"1268_CR98","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2249.1998.00673.x","volume":"113","author":"O Hajoui","year":"1998","unstructured":"Hajoui O, Martin S, Alvarez F. Study of antigenic sites on the asialoglycoprotein receptor recognized by autoantibodies. Clin Exp Immunol. 1998;113:339\u2013345.","journal-title":"Clin Exp Immunol"},{"key":"1268_CR99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2005.01.007","volume":"301","author":"T Schreiter","year":"2005","unstructured":"Schreiter T, Liu C, Gerken G, Treichel U. Detection of circulating autoantibodies directed against the asialoglycoprotein receptor using recombinant receptor subunit H1. J Immunol Methods. 2005;301:1\u201310.","journal-title":"J Immunol Methods"},{"key":"1268_CR100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0016-5085(84)90600-0","volume":"86","author":"M Mizuno","year":"1984","unstructured":"Mizuno M, Kloppel TM, Nakane PK, Brown WR, Vierling JM. Cellular distribution of the asialoglycoprotein receptor in rat liver. Implications for hepatic accumulation of desialylated lymphocytes. Gastroenterology. 1984;86:142\u2013149.","journal-title":"Gastroenterology"},{"key":"1268_CR101","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0016-5085(84)90068-4","volume":"87","author":"M Mizuno","year":"1984","unstructured":"Mizuno M, Brown WR, Vierling JM. Ultrastructural immunocytochemical localization of the asialoglycoprotein receptor in rat hepatocytes. Gastroenterology. 1984;87:763\u2013769.","journal-title":"Gastroenterology"},{"key":"1268_CR102","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1083\/jcb.111.4.1409","volume":"111","author":"YI Henis","year":"1990","unstructured":"Henis YI, Katzir Z, Shia MA, Lodish HF. Oligomeric structure of the human asialoglycoprotein receptor: nature and stoichiometry of mutual complexes containing H1 and H2 polypeptides assessed by fluorescence photobleaching recovery. J Cell Biol. 1990;111:1409\u20131418.","journal-title":"J Cell Biol"},{"key":"1268_CR103","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s10529-006-9064-0","volume":"28","author":"JH Park","year":"2006","unstructured":"Park JH, Kim KL, Cho EW. Detection of surface asialoglycoprotein receptor expression in hepatic and extra-hepatic cells using a novel monoclonal antibody. Biotechnol Lett. 2006;28:1061\u20131069.","journal-title":"Biotechnol Lett"},{"key":"1268_CR104","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/BF02919748","volume":"10","author":"KH Meyer zum Buschenfelde","year":"1991","unstructured":"Meyer zum Buschenfelde KH, Treichel U, Lohr H, Fleischer B, Poralla T. Human asialoglycoprotein receptor as an autoantigen in chronic hepatitis. Immunol Res. 1991;10:497\u2013502.","journal-title":"Immunol Res"},{"key":"1268_CR105","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0168-8278(86)80026-5","volume":"3","author":"BM McFarlane","year":"1986","unstructured":"McFarlane BM, McSorley CG, Vergani D, McFarlane IG, Williams R. Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders. J Hepatol. 1986;3:196\u2013205.","journal-title":"J Hepatol"},{"key":"1268_CR106","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/hep.1840110413","volume":"11","author":"U Treichel","year":"1990","unstructured":"Treichel U, Poralla T, Hess G, Manns M, Meyer zum Buschenfelde KH. Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis. Hepatology. 1990;11:606\u2013612.","journal-title":"Hepatology"},{"key":"1268_CR107","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0168-8278(05)80176-X","volume":"19","author":"U Treichel","year":"1993","unstructured":"Treichel U, Gerken G, Rossol S, et al. Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis. J Hepatol. 1993;19:55\u201363.","journal-title":"J Hepatol"},{"key":"1268_CR108","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0016-5085(94)90129-5","volume":"107","author":"U Treichel","year":"1994","unstructured":"Treichel U, McFarlane BM, Seki T, et al. Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterology. 1994;107:799\u2013804.","journal-title":"Gastroenterology"},{"key":"1268_CR109","first-page":"7","volume":"45","author":"P Husa","year":"2001","unstructured":"Husa P, Chalupa P, Stroblova H, et al. Autoantibodies to asialoglycoprotein receptor in chronic hepatitis C patients. Acta Virol. 2001;45:7\u201311.","journal-title":"Acta Virol"},{"key":"1268_CR110","first-page":"99","volume":"56","author":"M Yoshioka","year":"2002","unstructured":"Yoshioka M, Mizuno M, Morisue Y, et al. Anti-asialoglycoprotein receptor autoantibodies, detected by a capture-immunoassay, are associated with autoimmune liver diseases. Acta Med Okayama. 2002;56:99\u2013105.","journal-title":"Acta Med Okayama"},{"key":"1268_CR111","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s004310051278","volume":"159","author":"O Hajoui","year":"2000","unstructured":"Hajoui O, Debray D, Martin S, Alvarez F. Auto-antibodies to the asialoglycoprotein receptor in sera of children with auto-immune hepatitis. Eur J Pediatr. 2000;159:310\u2013313.","journal-title":"Eur J Pediatr"},{"key":"1268_CR112","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1440-1746.1990.tb01624.x","volume":"5","author":"PJ Johnson","year":"1990","unstructured":"Johnson PJ, McFarlane IG, McFarlane BM, Williams R. Auto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional auto-antibodies. J Gastroenterol Hepatol. 1990;5:244\u2013251.","journal-title":"J Gastroenterol Hepatol"},{"key":"1268_CR113","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/hep.1840120611","volume":"12","author":"H Lohr","year":"1990","unstructured":"Lohr H, Treichel U, Poralla T, et al. The human hepatic asialoglycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis. Hepatology. 1990;12:1314\u20131320.","journal-title":"Hepatology"},{"key":"1268_CR114","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2249.1992.tb03037.x","volume":"88","author":"H Lohr","year":"1992","unstructured":"Lohr H, Treichel U, Poralla T, Manns M, Meyer zum Buschenfelde KH. Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro. Clin Exp Immunol. 1992;88:45\u201349.","journal-title":"Clin Exp Immunol"},{"key":"1268_CR115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3727\/000000002783985756","volume":"11","author":"T Kakegawa","year":"2002","unstructured":"Kakegawa T, Ise H, Sugihara N, et al. Soluble asialoglycoprotein receptors reflect the apoptosis of hepatocytes. Cell Transplant. 2002;11:407\u2013415.","journal-title":"Cell Transplant"},{"key":"1268_CR116","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/hep.1840110312","volume":"11","author":"BM McFarlane","year":"1990","unstructured":"McFarlane BM, Sipos J, Gove CD, McFarlane IG, Williams R. Antibodies against the hepatic asialoglycoprotein receptor perfused in situ preferentially attach to periportal liver cells in the rat. Hepatology. 1990;11:408\u2013415.","journal-title":"Hepatology"},{"key":"1268_CR117","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.20172","volume":"39","author":"P Hilgard","year":"2004","unstructured":"Hilgard P, Schreiter T, Stockert RJ, Gerken G, Treichel U. Asialoglycoprotein receptor facilitates hemolysis in patients with alcoholic liver cirrhosis. Hepatology. 2004;39:1398\u20131407.","journal-title":"Hepatology"},{"key":"1268_CR118","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/hep.510250333","volume":"25","author":"J Diao","year":"1997","unstructured":"Diao J, Michalak TI. Virus-induced anti-asialoglycoprotein receptor autoimmunity in experimental hepadnaviral hepatitis. Hepatology. 1997;25:689\u2013696.","journal-title":"Hepatology"},{"key":"1268_CR119","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/hep.1840140621","volume":"14","author":"T Inamoto","year":"1991","unstructured":"Inamoto T, Brown WR. IgG is associated with the asialoglycoprotein receptor in the human liver. Hepatology. 1991;14:1070\u20131075.","journal-title":"Hepatology"},{"key":"1268_CR120","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/BF02088738","volume":"41","author":"AJ Czaja","year":"1996","unstructured":"Czaja AJ, Pfeifer KD, Decker RH, Vallari AS. Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis. Dig Dis Sci. 1996;41:1733\u20131740.","journal-title":"Dig Dis Sci"},{"key":"1268_CR121","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0140-6736(84)91167-X","volume":"2","author":"IG McFarlane","year":"1984","unstructured":"McFarlane IG, Hegarty JE, McSorley CG, McFarlane BM, Williams R. Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis. Lancet. 1984;2:954\u2013956.","journal-title":"Lancet"},{"key":"1268_CR122","first-page":"15","volume":"35","author":"D Dejica","year":"1997","unstructured":"Dejica D, Treichel U, Par A, Chira O, Meyer zum Buschenfelde KH. Anti asialoglycoprotein receptor antibodies and soluble interleukin-2 receptor levels as marker for inflammation in autoimmune hepatitis. Z Gastroenterol. 1997;35:15\u201321.","journal-title":"Z Gastroenterol"},{"key":"1268_CR123","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cca.2009.06.035","volume":"408","author":"G Hausdorf","year":"2009","unstructured":"Hausdorf G, Roggenbuck D, Feist E, et al. Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA\u2014revival of a disease-activity marker in autoimmune hepatitis. Clin Chim Acta. 2009;408:19\u201324.","journal-title":"Clin Chim Acta"},{"key":"1268_CR124","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.177.5.1367","volume":"177","author":"C Mohan","year":"1993","unstructured":"Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med. 1993;177:1367\u20131381.","journal-title":"J Exp Med"},{"key":"1268_CR125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004180050083","volume":"107","author":"D Doenecke","year":"1997","unstructured":"Doenecke D, Albig W, Bode C, et al. Histones: genetic diversity and tissue-specific gene expression. Histochem Cell Biol. 1997;107:1\u201310.","journal-title":"Histochem Cell Biol"},{"key":"1268_CR126","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1568-9972(02)00083-6","volume":"1","author":"RW Burlingame","year":"2002","unstructured":"Burlingame RW, Cervera R. Anti-chromatin (anti-nucleosome) autoantibodies. Autoimmun Rev. 2002;1:321\u2013328.","journal-title":"Autoimmun Rev"},{"key":"1268_CR127","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00002281-200009000-00003","volume":"12","author":"Z Amoura","year":"2000","unstructured":"Amoura Z, Koutouzov S, Piette JC. The role of nucleosomes in lupus. Curr Opin Rheumatol. 2000;12:369\u2013373.","journal-title":"Curr Opin Rheumatol"},{"key":"1268_CR128","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/art.1780371118","volume":"37","author":"Z Amoura","year":"1994","unstructured":"Amoura Z, Chabre H, Koutouzov S, et al. Nucleosome-restricted antibodies are detected before anti-dsDNA and\/or antihistone antibodies in serum of MRL-Mp lpr\/lpr and +\/+\u00a0mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum. 1994;37:1684\u20131688.","journal-title":"Arthritis Rheum"},{"key":"1268_CR129","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1172\/JCI117305","volume":"94","author":"RW Burlingame","year":"1994","unstructured":"Burlingame RW, Boey ML, Starkebaum G, Rubin RL. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest. 1994;94:184\u2013192.","journal-title":"J Clin Invest"},{"key":"1268_CR130","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1046\/j.1440-1746.2000.02325.x","volume":"15","author":"L Li","year":"2000","unstructured":"Li L, Chen M, Huang DY, Nishioka M. Frequency and significance of antibodies to chromatin in autoimmune hepatitis type I. J Gastroenterol Hepatol. 2000;15:1176\u20131182.","journal-title":"J Gastroenterol Hepatol"},{"key":"1268_CR131","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1023\/A:1024748714580","volume":"48","author":"AJ Czaja","year":"2003","unstructured":"Czaja AJ, Shums Z, Binder WL, et al. Frequency and significance of antibodies to chromatin in autoimmune hepatitis. Dig Dis Sci. 2003;48:1658\u20131664.","journal-title":"Dig Dis Sci"},{"key":"1268_CR132","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1824-7288-35-22","volume":"35","author":"LB El-Din Elshazly","year":"2009","unstructured":"El-Din Elshazly LB, Youssef AM, Mahmoud NH, Ibrahim MM. Study of nonstandard auto-antibodies as prognostic markers in auto immune hepatitis in children. Ital J Pediatr. 2009;35:22.","journal-title":"Ital J Pediatr"},{"key":"1268_CR133","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0016-5085(87)90122-3","volume":"92","author":"E Penner","year":"1987","unstructured":"Penner E. Nature of immune complexes in autoimmune chronic active hepatitis. Gastroenterology. 1987;92:304\u2013308.","journal-title":"Gastroenterology"},{"key":"1268_CR134","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0090-1229(89)90207-9","volume":"51","author":"F Konikoff","year":"1989","unstructured":"Konikoff F, Swissa M, Shoenfeld Y. Autoantibodies to histones and their subfractions in chronic liver diseases. Clin Immunol Immunopathol. 1989;51:77\u201382.","journal-title":"Clin Immunol Immunopathol"},{"key":"1268_CR135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0168-8278(95)80308-4","volume":"23","author":"AJ Czaja","year":"1995","unstructured":"Czaja AJ, Ming C, Shirai M, Nishioka M. Frequency and significance of antibodies to histones in autoimmune hepatitis. J Hepatol. 1995;23:32\u201338.","journal-title":"J Hepatol"},{"key":"1268_CR136","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1440-1746.1998.tb00673.x","volume":"13","author":"M Chen","year":"1998","unstructured":"Chen M, Shirai M, Czaja AJ, et al. Characterization of anti-histone antibodies in patients with type 1 autoimmune hepatitis. J Gastroenterol Hepatol. 1998;13:483\u2013489.","journal-title":"J Gastroenterol Hepatol"},{"key":"1268_CR137","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.510260306","volume":"26","author":"AJ Czaja","year":"1997","unstructured":"Czaja AJ, Morshed SA, Parveen S, Nishioka M. Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis. Hepatology. 1997;26:567\u2013572.","journal-title":"Hepatology"},{"key":"1268_CR138","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cccn.2004.07.016","volume":"350","author":"S Nijenhuis","year":"2004","unstructured":"Nijenhuis S, Zendman AJ, Vossenaar ER, Pruijn GJ, vanVenrooij WJ. Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker. Clin Chim Acta. 2004;350:17\u201334.","journal-title":"Clin Chim Acta"},{"key":"1268_CR139","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/08916930410001708733","volume":"37","author":"AJ Zendman","year":"2004","unstructured":"Zendman AJ, Vossenaar ER, van Venrooij WJ. Autoantibodies to citrullinated (poly)peptides: a key diagnostic and prognostic marker for rheumatoid arthritis. Autoimmunity. 2004;37:295\u2013299.","journal-title":"Autoimmunity"},{"key":"1268_CR140","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantapaa-Dahlqvist","year":"2003","unstructured":"Rantapaa-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48:2741\u20132749.","journal-title":"Arthritis Rheum"},{"key":"1268_CR141","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","volume":"43","author":"EJ Kroot","year":"2000","unstructured":"Kroot EJ, de Jong BA, van Leeuwen MA, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2000;43:1831\u20131835.","journal-title":"Arthritis Rheum"},{"key":"1268_CR142","doi-asserted-by":"crossref","first-page":"R458","DOI":"10.1186\/ar1697","volume":"7","author":"K Lundberg","year":"2005","unstructured":"Lundberg K, Nijenhuis S, Vossenaar ER, et al. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res Ther. 2005;7:R458\u2013R467.","journal-title":"Arthritis Res Ther"},{"key":"1268_CR143","first-page":"231","volume":"32","author":"K Raza","year":"2005","unstructured":"Raza K, Breese M, Nightingale P, et al. Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. J Rheumatol. 2005;32:231\u2013238.","journal-title":"J Rheumatol"},{"key":"1268_CR144","doi-asserted-by":"crossref","first-page":"R949","DOI":"10.1186\/ar1767","volume":"7","author":"AH n Mil","year":"2005","unstructured":"n Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther. 2005;7:R949\u2013R958.","journal-title":"Arthritis Res Ther"},{"key":"1268_CR145","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1365-2036.2005.02686.x","volume":"22","author":"M Fusconi","year":"2005","unstructured":"Fusconi M, Vannini A, Dall\u2019Aglio AC, et al. Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis. Aliment Pharmacol Ther. 2005;22:951\u2013955.","journal-title":"Aliment Pharmacol Ther"},{"key":"1268_CR146","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/08916930600783348","volume":"39","author":"A Montano-Loza","year":"2006","unstructured":"Montano-Loza A, Czaja AJ, Carpenter HA, et al. Frequency and significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis. Autoimmunity. 2006;39:341\u2013348.","journal-title":"Autoimmunity"},{"key":"1268_CR147","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/bies.10357","volume":"25","author":"ER Vossenaar","year":"2003","unstructured":"Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays. 2003;25:1106\u20131118.","journal-title":"Bioessays"},{"key":"1268_CR148","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/0016-5085(95)90211-2","volume":"108","author":"K Neubauer","year":"1995","unstructured":"Neubauer K, Knittel T, Armbrust T, Ramadori G. Accumulation and cellular localization of fibrinogen\/fibrin during short-term and long-term rat liver injury. Gastroenterology. 1995;108:1124\u20131135.","journal-title":"Gastroenterology"},{"key":"1268_CR149","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1586\/17474124.1.1.113","volume":"1","author":"AJ Czaja","year":"2007","unstructured":"Czaja AJ. Autoimmune hepatitis. Part A: pathogenesis. Expert Rev Gastroenterol Hepatol. 2007;1:113\u2013128.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1268_CR150","doi-asserted-by":"crossref","first-page":"36164","DOI":"10.1074\/jbc.M002180200","volume":"275","author":"CP Strassburg","year":"2000","unstructured":"Strassburg CP, Kneip S, Topp J, et al. Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine. J Biol Chem. 2000;275:36164\u201336171.","journal-title":"J Biol Chem"},{"key":"1268_CR151","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1124\/dmd.109.027227","volume":"37","author":"T Izukawa","year":"2009","unstructured":"Izukawa T, Nakajima M, Fujiwara R, et al. Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers. Drug Metab Dispos. 2009;37:1759\u20131768.","journal-title":"Drug Metab Dispos"},{"key":"1268_CR152","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2133\/dmpk.22.367","volume":"22","author":"Y Ishii","year":"2007","unstructured":"Ishii Y, Iwanaga M, Nishimura Y, et al. Protein\u2013protein interactions between rat hepatic cytochromes P450 (P450\u00a0s) and UDP-glucuronosyltransferases (UGTs): evidence for the functionally active UGT in P450-UGT complex. Drug Metab Pharmacokinet. 2007;22:367\u2013376.","journal-title":"Drug Metab Pharmacokinet"},{"key":"1268_CR153","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00351174","volume":"23","author":"P Obermayer-Straub","year":"1996","unstructured":"Obermayer-Straub P, Manns MP. Cytochrome P450 enzymes and UDP-glucuronosyltransferases as hepatocellular autoantigens. Mol Biol Rep. 1996;23:235\u2013242.","journal-title":"Mol Biol Rep"},{"key":"1268_CR154","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510260438","volume":"26","author":"MP Manns","year":"1997","unstructured":"Manns MP, Obermayer-Straub P. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease. Hepatology. 1997;26:1054\u20131066.","journal-title":"Hepatology"},{"key":"1268_CR155","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1155\/2000\/910107","volume":"14","author":"P Obermayer-Straub","year":"2000","unstructured":"Obermayer-Straub P, Strassburg CP, Manns MP. Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases. Can J Gastroenterol. 2000;14:429\u2013439.","journal-title":"Can J Gastroenterol"},{"key":"1268_CR156","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/08916930400001891","volume":"37","author":"M Shinoda","year":"2004","unstructured":"Shinoda M, Tanaka Y, Kuno T, et al. High levels of autoantibodies against drug-metabolizing enzymes in SLA\/LP-positive AIH-1 sera. Autoimmunity. 2004;37:473\u2013480.","journal-title":"Autoimmunity"},{"key":"1268_CR157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1568-9972(03)00051-X","volume":"3","author":"N Fabien","year":"2004","unstructured":"Fabien N, Desbos A, Bienvenu J, Magdalou J. Autoantibodies directed against the UDP-glucuronosyltransferases in human autoimmune hepatitis. Autoimmun Rev. 2004;3:1\u20139.","journal-title":"Autoimmun Rev"},{"key":"1268_CR158","first-page":"561","volume":"55","author":"JC Homberg","year":"1984","unstructured":"Homberg JC, Andre C, Abuaf N. A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis. Clin Exp Immunol. 1984;55:561\u2013570.","journal-title":"Clin Exp Immunol"},{"key":"1268_CR159","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/gut.30.4.515","volume":"30","author":"J Neuberger","year":"1989","unstructured":"Neuberger J, Williams R. Immune mechanisms in tienilic acid associated hepatotoxicity. Gut. 1989;30:515\u2013519.","journal-title":"Gut"},{"key":"1268_CR160","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0026-895X(25)09234-X","volume":"50","author":"S Lecoeur","year":"1996","unstructured":"Lecoeur S, Andre C, Beaune PH. Tienilic acid-induced autoimmune hepatitis: anti-liver and-kidney microsomal type 2 autoantibodies recognize a three-site conformational epitope on cytochrome P4502C9. Mol Pharmacol. 1996;50:326\u2013333.","journal-title":"Mol Pharmacol"},{"key":"1268_CR161","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.taap.2008.06.024","volume":"232","author":"T Nishiya","year":"2008","unstructured":"Nishiya T, Mori K, Hattori C, et al. The crucial protective role of glutathione against tienilic acid hepatotoxicity in rats. Toxicol Appl Pharmacol. 2008;232:280\u2013291.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1268_CR162","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0016-5085(96)70020-3","volume":"111","author":"CP Strassburg","year":"1996","unstructured":"Strassburg CP, Obermayer-Straub P, Alex B, et al. Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis. Gastroenterology. 1996;111:1576\u20131586.","journal-title":"Gastroenterology"},{"key":"1268_CR163","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0753-3322(96)82663-1","volume":"49","author":"T Philipp","year":"1995","unstructured":"Philipp T, Obermayer-Straub P, Manns MP. Autoantibodies in hepatitis delta. Biomed Pharmacother. 1995;49:344\u2013349.","journal-title":"Biomed Pharmacother"},{"key":"1268_CR164","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1572-0241.2001.03383.x","volume":"96","author":"A Csepregi","year":"2001","unstructured":"Csepregi A, Nemesanszky E, Luettig B, Obermayer-Straub P, Manns MP. LKM3 autoantibodies in hepatitis C cirrhosis: a further phenomenon of the HCV-induced autoimmunity. Am J Gastroenterol. 2001;96:910\u2013911.","journal-title":"Am J Gastroenterol"},{"key":"1268_CR165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00042737-200201000-00007","volume":"14","author":"GN Dalekos","year":"2002","unstructured":"Dalekos GN, Makri E, Loges S, et al. Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece. Eur J Gastroenterol Hepatol. 2002;14:35\u201342.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1268_CR166","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(94)91966-6","volume":"344","author":"T Philipp","year":"1994","unstructured":"Philipp T, Durazzo M, Trautwein C, et al. Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D. Lancet. 1994;344:578\u2013581.","journal-title":"Lancet"},{"key":"1268_CR167","first-page":"132","volume":"22","author":"T Philipp","year":"1995","unstructured":"Philipp T, Straub P, Durazzo M, Tukey RH, Manns MP. Molecular analysis of autoantigens in hepatitis D. J Hepatol. 1995;22:132\u2013135.","journal-title":"J Hepatol"},{"key":"1268_CR168","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0016-5085(95)90074-8","volume":"108","author":"M Durazzo","year":"1995","unstructured":"Durazzo M, Philipp T, Van Pelt FN, et al. Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection. Gastroenterology. 1995;108:455\u2013462.","journal-title":"Gastroenterology"},{"key":"1268_CR169","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-2005-916321","volume":"25","author":"P Invernizzi","year":"2005","unstructured":"Invernizzi P, Selmi C, Ranftler C, Podda M, Wesierska-Gadek J. Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis. 2005;25:298\u2013310.","journal-title":"Semin Liver Dis"},{"key":"1268_CR170","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","volume":"45","author":"M Nakamura","year":"2007","unstructured":"Nakamura M, Kondo H, Mori T, et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology. 2007;45:118\u2013127.","journal-title":"Hepatology"},{"key":"1268_CR171","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1572-0241.2003.07257.x","volume":"98","author":"P Muratori","year":"2003","unstructured":"Muratori P, Muratori L, Ferrari R, et al. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol. 2003;98:431\u2013437.","journal-title":"Am J Gastroenterol"},{"key":"1268_CR172","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1568-9972(03)00013-2","volume":"2","author":"HJ Worman","year":"2003","unstructured":"Worman HJ, Courvalin JC. Antinuclear antibodies specific for primary biliary cirrhosis. Autoimmun Rev. 2003;2:211\u2013217.","journal-title":"Autoimmun Rev"},{"key":"1268_CR173","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0016-5085(94)95333-3","volume":"106","author":"RE Nickowitz","year":"1994","unstructured":"Nickowitz RE, Wozniak RW, Schaffner F, Worman HJ. Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis. Gastroenterology. 1994;106:193\u2013199.","journal-title":"Gastroenterology"},{"key":"1268_CR174","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-2007-1007185","volume":"17","author":"JC Courvalin","year":"1997","unstructured":"Courvalin JC, Worman HJ. Nuclear envelope protein autoantibodies in primary biliary cirrhosis. Semin Liver Dis. 1997;17:79\u201390.","journal-title":"Semin Liver Dis"},{"key":"1268_CR175","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.cgh.2009.07.012","volume":"7","author":"P Milkiewicz","year":"2009","unstructured":"Milkiewicz P, Buwaneswaran H, Coltescu C, et al. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease. Clin Gastroenterol Hepatol. 2009;7:1355\u20131360.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1268_CR176","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/ajg.2009.596","volume":"105","author":"A Granito","year":"2010","unstructured":"Granito A, Yang WH, Muratori L, et al. PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. Am J Gastroenterol. 2010;105:125\u2013131.","journal-title":"Am J Gastroenterol"},{"key":"1268_CR177","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1073\/pnas.85.22.8531","volume":"85","author":"HJ Worman","year":"1988","unstructured":"Worman HJ, Yuan J, Blobel G, Georgatos SD. A lamin B receptor in the nuclear envelope. Proc Natl Acad Sci USA. 1988;85:8531\u20138534.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1268_CR178","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.172.3.961","volume":"172","author":"JC Courvalin","year":"1990","unstructured":"Courvalin JC, Lassoued K, Worman HJ, Blobel G. Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis. J Exp Med. 1990;172:961\u2013967.","journal-title":"J Exp Med"},{"key":"1268_CR179","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/hep.510280207","volume":"28","author":"B Terjung","year":"1998","unstructured":"Terjung B, Herzog V, Worman HJ, et al. Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins. Hepatology. 1998;28:332\u2013340.","journal-title":"Hepatology"},{"key":"1268_CR180","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1172\/JCI114696","volume":"86","author":"JC Courvalin","year":"1990","unstructured":"Courvalin JC, Lassoued K, Bartnik E, Blobel G, Wozniak RW. The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore. J Clin Invest. 1990;86:279\u2013285.","journal-title":"J Clin Invest"},{"key":"1268_CR181","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/hep.510230109","volume":"23","author":"F Lin","year":"1996","unstructured":"Lin F, Noyer CM, Ye Q, Courvalin JC, Worman HJ. Autoantibodies from patients with primary biliary cirrhosis recognize a region within the nucleoplasmic domain of inner nuclear membrane protein LBR. Hepatology. 1996;23:57\u201361.","journal-title":"Hepatology"},{"key":"1268_CR182","first-page":"113","volume":"35","author":"T Orth","year":"1997","unstructured":"Orth T, Gerken G, Meyer Zum Buschenfelde KH, Mayet WJ. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity. Z Gastroenterol. 1997;35:113\u2013121.","journal-title":"Z Gastroenterol"},{"key":"1268_CR183","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.4049\/jimmunol.145.12.4338","volume":"145","author":"C Szostecki","year":"1990","unstructured":"Szostecki C, Guldner HH, Netter HJ, Will H. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol. 1990;145:4338\u20134347.","journal-title":"J Immunol"},{"key":"1268_CR184","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-3083.1992.tb03224.x","volume":"36","author":"C Szostecki","year":"1992","unstructured":"Szostecki C, Will H, Netter HJ, Guldner HH. Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: epitope specificity and immunoglobulin class distribution. Scand J Immunol. 1992;36:555\u2013564.","journal-title":"Scand J Immunol"},{"key":"1268_CR185","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-3083.1995.tb03652.x","volume":"42","author":"T Sternsdorf","year":"1995","unstructured":"Sternsdorf T, Guldner HH, Szostecki C, Grotzinger T, Will H. Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand J Immunol. 1995;42:257\u2013268.","journal-title":"Scand J Immunol"},{"key":"1268_CR186","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0168-8278(98)80233-X","volume":"28","author":"B Luettig","year":"1998","unstructured":"Luettig B, Boeker KH, Schoessler W, et al. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis. J Hepatol. 1998;28:824\u2013828.","journal-title":"J Hepatol"},{"key":"1268_CR187","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1365-2249.2002.01719.x","volume":"127","author":"P Muratori","year":"2002","unstructured":"Muratori P, Muratori L, Cassani F, et al. Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders. Clin Exp Immunol. 2002;127:172\u2013175.","journal-title":"Clin Exp Immunol"},{"key":"1268_CR188","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1478-3231.2004.0924.x","volume":"24","author":"AJ Czaja","year":"2004","unstructured":"Czaja AJ, Muratori P, Muratori L, Carpenter HA, Bianchi FB. Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. Liver Int. 2004;24:322\u2013329.","journal-title":"Liver Int"},{"key":"1268_CR189","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1080\/00365520310004876","volume":"38","author":"I Wichmann","year":"2003","unstructured":"Wichmann I, Montes-Cano MA, Respaldiza N, et al. Clinical significance of anti-multiple nuclear dots\/Sp100 autoantibodies. Scand J Gastroenterol. 2003;38:996\u2013999.","journal-title":"Scand J Gastroenterol"},{"key":"1268_CR190","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1196\/annals.1398.024","volume":"1109","author":"J Manuel Lucena","year":"2007","unstructured":"Manuel Lucena J, Montes Cano M, Luis Caro J, et al. Comparison of two ELISA assays for anti-Sp100 determination. Ann NY Acad Sci. 2007;1109:203\u2013211.","journal-title":"Ann NY Acad Sci"},{"key":"1268_CR191","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2249.2004.02332.x","volume":"135","author":"P Muratori","year":"2004","unstructured":"Muratori P, Muratori L, Gershwin ME, et al. \u2018True\u2019 antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? Clin Exp Immunol. 2004;135:154\u2013158.","journal-title":"Clin Exp Immunol"},{"key":"1268_CR192","first-page":"1123","volume":"26","author":"D Zuchner","year":"1997","unstructured":"Zuchner D, Sternsdorf T, Szostecki C, et al. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis. Hepatology. 1997;26:1123\u20131130.","journal-title":"Hepatology"},{"key":"1268_CR193","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0016-5085(03)00387-1","volume":"124","author":"S Shimoda","year":"2003","unstructured":"Shimoda S, Nakamura M, Ishibashi H, et al. Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis. Gastroenterology. 2003;124:1915\u20131925.","journal-title":"Gastroenterology"},{"key":"1268_CR194","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1590-8658(03)00466-3","volume":"35","author":"DP Bogdanos","year":"2003","unstructured":"Bogdanos DP, Baum H, Butler P, et al. Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection. Dig Liver Dis. 2003;35:801\u2013805.","journal-title":"Dig Liver Dis"},{"issue":"Suppl 3","key":"1268_CR195","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1111\/j.1872-034X.2007.00227.x","volume":"37","author":"HJ Worman","year":"2007","unstructured":"Worman HJ. Nuclear envelope protein autoantigens in primary biliary cirrhosis. Hepatol Res. 2007;37(Suppl 3):S406\u2013S411.","journal-title":"Hepatol Res"},{"issue":"Suppl 3","key":"1268_CR196","doi-asserted-by":"crossref","first-page":"S412","DOI":"10.1111\/j.1872-034X.2007.00244.x","volume":"37","author":"M Nakamura","year":"2007","unstructured":"Nakamura M, Komori A, Ito M, et al. Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis. Hepatol Res. 2007;37(Suppl 3):S412\u2013S419.","journal-title":"Hepatol Res"},{"key":"1268_CR197","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10238-008-0150-6","volume":"8","author":"L Gao","year":"2008","unstructured":"Gao L, Tian X, Liu B, Zhang F. The value of antinuclear antibodies in primary biliary cirrhosis. Clin Exp Med. 2008;8:9\u201315.","journal-title":"Clin Exp Med"},{"key":"1268_CR198","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1126\/science.270.5242.1591","volume":"270","author":"AF Pluta","year":"1995","unstructured":"Pluta AF, Mackay AM, Ainsztein AM, Goldberg IG, Earnshaw WC. The centromere: hub of chromosomal activities. Science. 1995;270:1591\u20131594.","journal-title":"Science"},{"key":"1268_CR199","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1590\/S0100-879X2002000500001","volume":"35","author":"P Bjerling","year":"2002","unstructured":"Bjerling P, Ekwall K. Centromere domain organization and histone modifications. Braz J Med Biol Res. 2002;35:499\u2013507.","journal-title":"Braz J Med Biol Res"},{"key":"1268_CR200","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/ard.41.6.612","volume":"41","author":"RM Bernstein","year":"1982","unstructured":"Bernstein RM, Callender ME, Neuberger JM, Hughes GR, Williams R. Anticentromere antibody in primary biliary cirrhosis. Ann Rheum Dis. 1982;41:612\u2013614.","journal-title":"Ann Rheum Dis"},{"key":"1268_CR201","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2249.1990.tb03325.x","volume":"81","author":"NJ McHugh","year":"1990","unstructured":"McHugh NJ, James IE, Fairburn K, Maddison PJ. Autoantibodies to mitochondrial and centromere antigens in primary biliary cirrhosis and systemic sclerosis. Clin Exp Immunol. 1990;81:244\u2013249.","journal-title":"Clin Exp Immunol"},{"key":"1268_CR202","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3109\/00365529108998588","volume":"26","author":"BU Hansen","year":"1991","unstructured":"Hansen BU, Eriksson S, Lindgren S. High prevalence of autoimmune liver disease in patients with multiple nuclear dot, anti-centromere, and mitotic spindle antibodies. Scand J Gastroenterol. 1991;26:707\u2013713.","journal-title":"Scand J Gastroenterol"},{"key":"1268_CR203","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2230.1994.tb01199.x","volume":"19","author":"HL Chan","year":"1994","unstructured":"Chan HL, Lee YS, Hong HS, Kuo TT. Anticentromere antibodies (ACA): clinical distribution and disease specificity. Clin Exp Dermatol. 1994;19:298\u2013302.","journal-title":"Clin Exp Dermatol"},{"key":"1268_CR204","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1440-1746.1995.tb01597.x","volume":"10","author":"S Parveen","year":"1995","unstructured":"Parveen S, Morshed SA, Nishioka M. High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities. J Gastroenterol Hepatol. 1995;10:438\u2013445.","journal-title":"J Gastroenterol Hepatol"},{"key":"1268_CR205","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2036.2007.03433.x","volume":"26","author":"A Granito","year":"2007","unstructured":"Granito A, Muratori P, Muratori L, et al. Antibodies to SS-A\/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. Aliment Pharmacol Ther. 2007;26:831\u2013838.","journal-title":"Aliment Pharmacol Ther"},{"key":"1268_CR206","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3109\/s10165-007-0631-6","volume":"17","author":"K Takada","year":"2007","unstructured":"Takada K, Suzuki K, Matsumoto M, et al. Primary biliary cirrhosis in female subjects with sicca-associated antibodies. Mod Rheumatol. 2007;17:486\u2013491.","journal-title":"Mod Rheumatol"},{"key":"1268_CR207","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/rheumatology\/34.5.407","volume":"34","author":"J Whyte","year":"1995","unstructured":"Whyte J, Soriano E, Earnshaw WC, McHugh NJ. Frequency of autoantibodies to a major epitope on the carboxyl terminal fragment of CENP-B in patients with autoimmune disease. Br J Rheumatol. 1995;34:407\u2013412.","journal-title":"Br J Rheumatol"},{"key":"1268_CR208","first-page":"1488","volume":"32","author":"S Miyawaki","year":"2005","unstructured":"Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y. Clinical and serological heterogeneity in patients with anticentromere antibodies. J Rheumatol. 2005;32:1488\u20131494.","journal-title":"J Rheumatol"},{"key":"1268_CR209","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/jaut.1994.1008","volume":"7","author":"G Stahnke","year":"1994","unstructured":"Stahnke G, Meier E, Scanarini M, Northemann W. Eukaryotic expression of recombinant human centromere autoantigen and its use in a novel ELISA for diagnosis of CREST syndrome. J Autoimmun. 1994;7:107\u2013118.","journal-title":"J Autoimmun"},{"key":"1268_CR210","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s10620-008-0359-y","volume":"54","author":"T Himoto","year":"2009","unstructured":"Himoto T, Nakai S, Kinekawa F, et al. Clinical characteristics of patients with hepatitis C virus-related chronic liver disease seropositive for anticentromere antibody. Dig Dis Sci. 2009;54:360\u2013368.","journal-title":"Dig Dis Sci"},{"key":"1268_CR211","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1023\/A:1018880429469","volume":"43","author":"S Parveen","year":"1998","unstructured":"Parveen S, Morshed SA, Arima K, et al. Antibodies to Ro\/La, Cenp-B, and snRNPs antigens in autoimmune hepatitis of North America versus Asia: patterns of immunofluorescence, ELISA reactivities, and HLA association. Dig Dis Sci. 1998;43:1322\u20131331.","journal-title":"Dig Dis Sci"},{"key":"1268_CR212","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1542-3565(04)00465-3","volume":"2","author":"WH Yang","year":"2004","unstructured":"Yang WH, Yu JH, Nakajima A, et al. Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure? Clin Gastroenterol Hepatol. 2004;2:1116\u20131122.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1268_CR213","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3899\/jrheum.090340","volume":"36","author":"S Assassi","year":"2009","unstructured":"Assassi S, Fritzler MJ, Arnett FC, et al. Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol. 2009;36:2250\u20132256.","journal-title":"J Rheumatol"},{"key":"1268_CR214","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/MCG.0b013e3181587d18","volume":"42","author":"AJ Montano-Loza","year":"2008","unstructured":"Montano-Loza AJ, Carpenter HA, Czaja AJ. Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis. J Clin Gastroenterol. 2008;42:1047\u20131053.","journal-title":"J Clin Gastroenterol"},{"key":"1268_CR215","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","volume":"41","author":"D Vergani","year":"2004","unstructured":"Vergani D, Alvarez F, Bianchi FB, et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol. 2004;41:677\u2013683.","journal-title":"J Hepatol"},{"key":"1268_CR216","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1034\/j.1600-0676.2001.021004225.x","volume":"21","author":"DP Bogdanos","year":"2001","unstructured":"Bogdanos DP, Choudhuri K, Vergani D. Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences. Liver. 2001;21:225\u2013232.","journal-title":"Liver"},{"key":"1268_CR217","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1572-0241.2001.03707.x","volume":"96","author":"AJ Czaja","year":"2001","unstructured":"Czaja AJ. Understanding the pathogenesis of autoimmune hepatitis. Am J Gastroenterol. 2001;96:1224\u20131231.","journal-title":"Am J Gastroenterol"},{"key":"1268_CR218","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.trsl.2006.11.010","volume":"149","author":"P Lapierre","year":"2007","unstructured":"Lapierre P, Beland K, Alvarez F. Pathogenesis of autoimmune hepatitis: from break of tolerance to immune-mediated hepatocyte apoptosis. Transl Res. 2007;149:107\u2013113.","journal-title":"Transl Res"},{"key":"1268_CR219","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.3748\/wjg.14.3306","volume":"14","author":"D Vergani","year":"2008","unstructured":"Vergani D, Mieli-Vergani G. Aetiopathogenesis of autoimmune hepatitis. World J Gastroenterol. 2008;14:3306\u20133312.","journal-title":"World J Gastroenterol"},{"key":"1268_CR220","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2009.08.010","volume":"34","author":"MS Longhi","year":"2009","unstructured":"Longhi MS, Ma Y, Mieli-Vergani G, Vergani D. Aetiopathogenesis of autoimmune hepatitis. J Autoimmun. 2009;34:7\u201314.","journal-title":"J Autoimmun"},{"key":"1268_CR221","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/hep.22271","volume":"47","author":"J Herkel","year":"2008","unstructured":"Herkel J, Lohse AW. Significance of autoantibodies. Hepatology. 2008;47:786\u2013788.","journal-title":"Hepatology"},{"key":"1268_CR222","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cgh.2007.12.048","volume":"6","author":"AJ Czaja","year":"2008","unstructured":"Czaja AJ. Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis. Clin Gastroenterol Hepatol. 2008;6:379\u2013388.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1268_CR223","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10620-006-9495-4","volume":"52","author":"P Muratori","year":"2007","unstructured":"Muratori P, Czaja AJ, Muratori L, et al. Evidence of a genetic basis for the different geographic occurrences of liver\/kidney microsomal antibody type 1 in hepatitis C. Dig Dis Sci. 2007;52:179\u2013184.","journal-title":"Dig Dis Sci"},{"key":"1268_CR224","first-page":"108","volume":"68","author":"C Szostecki","year":"1987","unstructured":"Szostecki C, Krippner H, Penner E, Bautz FA. Autoimmune sera recognize a 100-kD nuclear protein antigen (sp-100). Clin Exp Immunol. 1987;68:108\u2013116.","journal-title":"Clin Exp Immunol"},{"key":"1268_CR225","doi-asserted-by":"crossref","unstructured":"Czaja AJ. Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis. Dig Dis Sci (in press).","DOI":"10.1007\/s10620-009-1122-8"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1268-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-010-1268-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1268-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T15:55:43Z","timestamp":1740066943000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-010-1268-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,13]]},"references-count":225,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["1268"],"URL":"https:\/\/doi.org\/10.1007\/s10620-010-1268-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,13]]}}}